Market Tracker

10/21 4:29am ET

Alimera Sciences Inc (NASDAQ:ALIM)

4.88
Data as of Oct 20
 +0.03 / +0.62%
Today’s Change
1.76
Today|||52-Week Range
8.44
+3.83%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close4.85
Today’s open4.85
Day’s range-- - --
Volume223,163
Average volume (3 months)281,597
Market cap$208.4M
Dividend yield--
Data as of 10/20/2014

Growth & Valuation

Earnings growth (last year)-157.14%
Earnings growth (this year)-29.52%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales79.29
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NNVCNanoViricides Inc-0.14-3.78%
HRTXHeron Therapeutics I...+0.18+2.51%
NAVBNavidea Biopharmaceu...+0.02+1.43%
AMPEAmpio Pharmaceutical...-0.16-3.85%
Data as of 10/20/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$1.9M
Annual profit (last year)-$51.2M
Net profit margin-2,733.92%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles Daniel Myers
Secretary, Chief Operating &
Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts